Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excimer lamp with or without topical mometasone for facial vitiligo
TCTR20200204004Completed
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mometasone in Vitiligo (2 arms), sponsored by none. Primary endpoint: Repigmentation at 12 weeks (visual assessment). Started Aug 2018; status: completed.
02
Drugs
mometasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on TCTR20200204004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200204004.